PRESS RELEASE - 8/2/17

New York, NY -- August 02, 2017 -- InvestorsHub NewsWire -- Rising India's (OTC: RSII) Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces that the Company has entered in the FDA testing phase on its revolutionary medical creams for chronic pain relief and neuropathic pain. These two pain creams will be the first in a series of products. Rising Biosciences, Inc. has retained an industry leading formulator and manufacturer of scientifically proven, innovative personal care products in anticipation for its testing phase of a full suite of OTC (over-the-c

Recent Posts
Archive

Follow

  • Facebook Social Icon

© 2019 RISING BIOSCIENCES, INC.